Delivery Order SPE2DB20D2104-SPE2DB25FMFRE

Award Date 1/7/25
Potential Completion Date 1/8/25
Potential Value $4.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,194.26 firm fixed-price delivery order is for 4566737140 - VALSARTAN-HCTZ 320-12.5 MG TAB 90S, a cardiovascular medication, with an ultimate completion date of December 17, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a $4,736.48 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 160 mg-25 mg valsartan-hydrochlorothiazide tablets in 90-count bottles. The contract has an ultimate completion date of April 26, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,235.09 firm fixed-price delivery order is for the supply of 4,566,676,103 units of the cardiovascular medication Valsartan-HCTZ 160-12.5 mg tablets. The contract has an ultimate completion date of December 11, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,985.62 firm fixed price delivery order is for the supply of 4566846812 VALSARTAN-HCTZ 80-12.5 MG TAB 90S, with a period of performance through January 7, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,831.16, is for the supply of VALSARTAN-HCTZ 160-12.5 MG TAB 90S, a cardiovascular medication. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of January 24, 2025. The contract is not designated with any set-aside requirements, indicating...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,786.63 firm fixed-price delivery order is for the supply of 4565682065 VALSARTAN-HCTZ 160-12.5 MG TAB 90S, a prescription medication. The award has an ultimate completion date of September 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,497.12 firm fixed-price delivery order is for the supply of VALSARTAN-HCTZ 160-25 MG TAB 90S, a cardiovascular medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Valsartan-HCTZ 320-12.5 mg tablets, a cardiovascular medication, with a ceiling value of $2,337.78. The contract is a delivery order under an existing Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,332.06, is for the delivery of Valsartan-HCTZ 160-12.5 mg tablets. This is a firm fixed-price delivery order contract with an ultimate completion date of October 1, 2024. AmerisourceBergen is a significant supplier of pharmaceutical products and medical supplies to various government agencies, including the...
This is a $6,143.82 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of 4,565,191,552 units of the pharmaceutical product Valsartan-HCTZ 320-25 mg tablets, with a completion date of July 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMFRE
    Delivery Order

This is a $4,312.74 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the supply of 4566862371 VALSARTAN-HCTZ 320-25 MG TAB 90S, a cardiovascular medication. The contract has an ultimate completion date of January 8, 2025.

AmerisourceBergen Drug Corp. is a major pharmaceutical distributor that specializes in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The company holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is issued under that IDC.

The contract award does not have a set-aside designation, indicating open competition. As a large, for-profit corporation, AmerisourceBergen Drug Corp. is the prime contractor on this award, with no major subcontractors identified.

Generated 4/8/25, 9:59 AM